OSE Immunotherapeutics
is a France-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases... Read moreOSE Immunotherapeutics
is a France-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases... Read more
News
AI
Jan 30, 2025
FinanzNachrichten
OSE (PAR: OSE) launches AI immunotherapy partnership
Partnership
Jan 29, 2025
HIT Consultant Media
OSE Immunotherapeutics & Scienta Lab Partner to Advance AI-Driven Drug Discovery
Leadership Change
Jan 17, 2025
GlobeNewswire
Sonya Montgomery joined OSE Immunotherapeutics as Chief Development Officer
Funding
Apr 10, 2024
GlobalNewswire
OSE Immunotherapeutics received $9.1M in Grant Funding
OSE Immunotherapeutics Competitors
1
2
3
4
5
6
7
8
9
10